Comment by refurb

You’re putting more things I. The FDA’s regulatory basket than the law intends.

Whether or not “people who could benefit have access” is not relevant to the FDA’s mandate. The intent of the FDA is to regulate the safety and efficacy of medicines - not access, not price.

Once supply was addressed, the FDA’s regulatory objectives were complete